This filing details transactions made by John M. Dineen, a director at COGNIZANT TECHNOLOGY SOLUTIONS CORP (CTSH). On May 27, 2026, Mr. Dineen acquired a total of 187.9891 restricted stock units (RSUs) through dividend equivalents. These RSUs, representing rights to Class A Common Stock, are fully vested but their sett...

This Form 4 filing reports that Karima Silvent, a director of Cognizant Technology Solutions Corp (CTSH), received 18.0122 restricted stock units on May 27, 2026. These units represent dividend equivalent rights accrued on previously outstanding restricted stock units, with each unit convertible to one share of Class A...

Abraham Schot, a director at COGNIZANT TECHNOLOGY SOLUTIONS CORP (CTSH), reported a transaction on May 27, 2026. The filing indicates the acquisition of 18.0122 Restricted Stock Units (RSUs) as a result of dividend equivalents accrued on previously held RSUs. Each RSU is convertible into one share of Class A Common Sto...

Kimberly G. Coldiron, SVP, CHRO of AMERICAN WOODMARK CORP, reported a disposition of 15,708 shares of Common Stock on May 28, 2026. This transaction occurred pursuant to an Agreement and Plan of Merger dated August 5, 2025, which resulted in the company surviving as a wholly owned subsidiary of MasterBrand, Inc. The fi...

Ronald E. Nelson, a director of Columbia Sportswear Company, exercised stock options and sold shares on May 27, 2026. He exercised two sets of stock options: 3,264 shares at an exercise price of $56.86 per share (originally granted June 10, 2016) and 816 shares at the same exercise price. Following the exercise, Nelson...

Donald A. Colvin, a director at Agilys Inc., was granted 1424 Restricted Stock Units (RSUs) on May 27, 2026. These RSUs, which represent a contingent right to receive one share of Agilys Inc. common stock, are part of the Agilys Inc. 2024 Equity Incentive Plan. The RSUs are set to vest on May 27, 2027. Following this t...

This filing reports a transaction by Roberval Tavares de Sousa, identified as an Engineering Officer of COMPANHIA DE SANEAMENTO BASICO DO ESTADO DE SAO PAULO-SABESP (SBS). On May 25, 2026, Mr. de Sousa disposed of 5,900 common shares at a price of $28.81 per share. Following this transaction, he holds 76 common shares ...

This filing reports on a derivative transaction involving Jeffrey M. Jonas, a director at COMPASS Pathways plc. On May 27, 2026, Mr. Jonas acquired a stock option to purchase 21,110 ordinary shares at an exercise price of $11.85 per share. The option is exercisable upon the earlier of the first anniversary of the grant...

This filing details a Form 4 submission by Gino Santini, a director at COMPASS Pathways plc. On May 27, 2026, Santini was granted a stock option to acquire 30,158 ordinary shares at an exercise price of $11.85 per share. The option vests in full on the earlier of the first anniversary of the grant date or the date of t...

This Form 4 filing details a stock option grant to Riley Wayne Joseph, a director at COMPASS Pathways plc. The grant, dated May 27, 2026, includes 21,110 share options with an exercise price of $11.85. These options vest in full on the earlier of the first anniversary of the grant date or the 2027 Annual General Meetin...

Norton David Y, a director at COMPASS Pathways plc, acquired 21,110 options for ordinary shares on May 27, 2026. The options have an exercise price of $11.85 and vest fully on the earlier of the first anniversary of the grant date or the 2027 Annual General Meeting. The shares underlying the options may be represented ...

This filing details a Form 4 filing by Justin D. Gover, a director at COMPASS Pathways plc. On May 27, 2026, Gover acquired 21,110 "Share Option (Right to Buy)" securities with a transaction code "A", indicating an acquisition. The options have an exercise price of $11.85 and are exercisable upon the earlier of the fir...

Daphne Karydas, a director at COMPASS Pathways plc, was granted 21,110 share options on May 27, 2026. These options have an exercise price of $11.85 and are exercisable upon the earlier of the first anniversary of the grant date or the 2027 Annual General Meeting. The options vest in full on May 27, 2027. The underlyin...

Kathleen Tregoning, a director at COMPASS Pathways plc, was granted 41,119 share options on May 27, 2026. These options, with an exercise price of $11.85, are exercisable starting June 27, 2026, and vest in 36 equal monthly installments over three years. The options are for Ordinary Shares, which may be represented by ...

This Form 4 filing discloses that Robert McQuade, a director of COMPASS Pathways plc, received an award of 21,110 stock options on May 27, 2026. The options have an exercise price of $11.85 per share and expire on May 26, 2036. The options vest in full upon the earlier of (i) the first anniversary of the grant date or ...

James N. Wilson, a director of Corcept Therapeutics Inc., filed a Form 4 disclosing significant share transfers on May 27, 2026. Wilson transferred 892,056 shares from James and Pamela Wilson Family Partners, reducing that holding to 9,011 shares, then transferred those remaining 9,011 shares to the James N. Wilson and...

This filing details stock transactions by Sean Maduck, an officer at Corcept Therapeutics Inc. On May 27, 2026, Maduck acquired 75,000 shares of Common Stock at a price of $8.27 per share, increasing his post-transaction holdings to 83,977 shares. This acquisition was linked to the exercise of a stock option. Additiona...

Joseph Douglas Lyon, Chief Accounting & Technology Officer of Corcept Therapeutics Inc., reported a sale of 5,000 shares of Common Stock on May 27, 2026, at a price of $65.00 per share. This transaction resulted in a post-transaction ownership of 6,230 shares. The filing also notes that 749 shares are subject to unvest...

This filing details transactions made by Ronald Clarke, CEO & Chairman of the Board of Directors of CORPAY, INC. On May 28, 2026, Clarke acquired 100,000 shares of Common Stock at a price of $150.74 per share, increasing his post-transaction holdings to 2,476,383 shares. Concurrently, he disposed of 68,150 shares of Co...

Armando Lins, Group President Brazil & US Veh Pmt at CORPAY, INC. (CPAY), reported several transactions of company common stock. On May 27, 2026, 418 shares were disposed of at a price of $355.08 per share, resulting in 32,617 shares remaining. The following day, May 28, 2026, a larger disposition of 14,089 shares occu...

Jill Taymans, VP Finance and CFO of CRYO CELL INTERNATIONAL INC, reported a transaction on May 28, 2026. Taymans acquired 7,500 shares of Common Stock at a price of $3.10 per share, increasing her post-transaction holdings to 52,896 shares. Concurrently, Taymans disposed of 7,500 Stock Options with an exercise price of...

This filing details transactions made by Tong Hairihan, Chief Technology Officer of CTW Cayman. On May 27, 2026, 800 stock options were exercised with a conversion or exercise price of $1.75, resulting in the acquisition of 800 Class A ordinary shares. These options became exercisable on December 17, 2025, and are set ...

Stephen Cummings, a director at Bank of N.T. Butterfield & Son Ltd (NTB), acquired 49 Restricted Stock Units (RSUs) under the EDIP plan on May 27, 2026. These RSUs represent a contingent right to receive one common share upon vesting. The RSUs vest over two years, subject to continued service, with vesting occurring 30...

This filing details stock transactions by Pham Quang X, CEO and Chairman of Cadrenal Therapeutics, Inc. (CVKD). On May 11, 2026, 6,476 shares of Common Stock were sold at a weighted average price of $5.76, with prices ranging from $5.47 to $6.12, under a Rule 10b5-1 trading arrangement. On May 12, 2026, 3,298 shares we...

This Form 4 filing reports that Russell L. Fleischer, a director of Callaway Golf Co (CALY), received 18,546 shares of common stock on May 29, 2026 through the vesting of Restricted Stock Units (RSUs). The RSUs were originally granted on May 29, 2025 and vested in full on their first anniversary. Following this transac...